These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33546112)

  • 41. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
    Lyu Y; Li X; Gong Y
    Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y; Li L; Xu G; Wang W
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR DIAMETER IN ACTIVE AND RESOLVED CENTRAL SEROUS CHORIORETINOPATHY.
    Chung YR; Kim JW; Choi SY; Park SW; Kim JH; Lee K
    Retina; 2018 Jan; 38(1):102-107. PubMed ID: 28106708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors for recurrence in acute central serous chorioretinopathy patients underwent one-third dose verteporfin photodynamic therapy.
    Zhang X; Zhuang X; Dong J; Fu B; Xu L
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():102984. PubMed ID: 35753673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
    Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term results of focal laser photocoagulation and photodynamic therapy for the treatment of central serous chorioretinopathy.
    Shin YI; Kim KM; Lee MW; Kim JY; Jo YJ
    Jpn J Ophthalmol; 2020 Jan; 64(1):28-36. PubMed ID: 31863228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy.
    Jeong S; Kang W; Noh D; van Hemert J; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1887-1898. PubMed ID: 35022815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy.
    Hanumunthadu D; Matet A; Rasheed MA; Goud A; Vuppurabina KK; Chhablani J
    Indian J Ophthalmol; 2019 Nov; 67(11):1850-1854. PubMed ID: 31638047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SUBFOVEAL CHOROIDAL THICKNESS CHANGES IN TREATED IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY AND THEIR ASSOCIATION WITH RECURRENCE.
    Kim DY; Joe SG; Yang HS; Lee JY; Kim JG; Yoon YH
    Retina; 2015 Sep; 35(9):1867-74. PubMed ID: 25946693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chan SY; Wang Q; Wei WB; Jonas JB
    Retina; 2016 Nov; 36(11):2051-2058. PubMed ID: 27164548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003.
    Yannuzzi LA; Slakter JS; Gross NE; Spaide RF; Costa DL; Huang SJ; Klancnik JM; Aizman A
    Retina; 2012 Feb; 32 Suppl 1():288-98. PubMed ID: 22451952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinal and choroidal vasoreactivity in central serous chorioretinopathy.
    Penas S; Araújo T; Mendonça AM; Faria S; Silva J; Campilho A; Martins ML; Sousa V; Rocha-Sousa A; Carneiro Â; Falcão-Reis F
    Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3825-3836. PubMed ID: 35838808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy.
    Han JY; Kim YJ; Choi EY; Lee J; Lee JH; Kim M; Byeon SH; Kim SS; Lee CS
    Yonsei Med J; 2022 Apr; 63(4):365-371. PubMed ID: 35352888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
    Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
    Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy.
    Terao N; Imanaga N; Wakugawa S; Sawaguchi S; Tamashiro T; Yamauchi Y; Koizumi H
    Ophthalmol Sci; 2021 Dec; 1(4):100071. PubMed ID: 36246946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy.
    Iida T; Kishi S; Hagimura N; Shimizu K
    Retina; 1999; 19(6):508-12. PubMed ID: 10606450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy.
    Ambiya V; Yogi R; Li A; Shah S; Sarvaiya C; Mehta P; Meyerele C; Wu L; Singh R; Banker A; Chhablani J
    Eye (Lond); 2016 Dec; 30(12):1623-1629. PubMed ID: 27689964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?
    Hwang H; Kim JY; Kim KT; Chae JB; Kim DY
    Retina; 2020 Sep; 40(9):1724-1733. PubMed ID: 31584559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.